185 related articles for article (PubMed ID: 20360126)
1. Validation of an enzyme immunoassay for detection and semiquantification of cannabinoids in oral fluid.
Schwope DM; Milman G; Huestis MA
Clin Chem; 2010 Jun; 56(6):1007-14. PubMed ID: 20360126
[TBL] [Abstract][Full Text] [Related]
2. Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence.
Lee D; Milman G; Barnes AJ; Goodwin RS; Hirvonen J; Huestis MA
Clin Chem; 2011 Aug; 57(8):1127-36. PubMed ID: 21677094
[TBL] [Abstract][Full Text] [Related]
3. Quantification of six cannabinoids and metabolites in oral fluid by liquid chromatography-tandem mass spectrometry.
Desrosiers NA; Scheidweiler KB; Huestis MA
Drug Test Anal; 2015 Aug; 7(8):684-94. PubMed ID: 25428610
[TBL] [Abstract][Full Text] [Related]
4. Disposition of cannabinoids in oral fluid after controlled around-the-clock oral THC administration.
Milman G; Barnes AJ; Schwope DM; Schwilke EW; Darwin WD; Goodwin RS; Kelly DL; Gorelick DA; Huestis MA
Clin Chem; 2010 Aug; 56(8):1261-9. PubMed ID: 20530732
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoids and metabolites in expectorated oral fluid after 8 days of controlled around-the-clock oral THC administration.
Milman G; Barnes AJ; Schwope DM; Schwilke EW; Goodwin RS; Kelly DL; Gorelick DA; Huestis MA
Anal Bioanal Chem; 2011 Aug; 401(2):599-607. PubMed ID: 21637933
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous quantification of cannabinoids and metabolites in oral fluid by two-dimensional gas chromatography mass spectrometry.
Milman G; Barnes AJ; Lowe RH; Huestis MA
J Chromatogr A; 2010 Feb; 1217(9):1513-21. PubMed ID: 20083251
[TBL] [Abstract][Full Text] [Related]
7. Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking.
Lee D; Vandrey R; Mendu DR; Murray JA; Barnes AJ; Huestis MA
Drug Test Anal; 2015 Jun; 7(6):494-501. PubMed ID: 25220020
[TBL] [Abstract][Full Text] [Related]
8. Passive cannabis smoke exposure and oral fluid testing.
Niedbala S; Kardos K; Salamone S; Fritch D; Bronsgeest M; Cone EJ
J Anal Toxicol; 2004 Oct; 28(7):546-52. PubMed ID: 15516313
[TBL] [Abstract][Full Text] [Related]
9. On-site test for cannabinoids in oral fluid.
Desrosiers NA; Lee D; Schwope DM; Milman G; Barnes AJ; Gorelick DA; Huestis MA
Clin Chem; 2012 Oct; 58(10):1418-25. PubMed ID: 22912396
[TBL] [Abstract][Full Text] [Related]
10. Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle.
Niedbala RS; Kardos KW; Fritch DF; Kunsman KP; Blum KA; Newland GA; Waga J; Kurtz L; Bronsgeest M; Cone EJ
J Anal Toxicol; 2005 Oct; 29(7):607-15. PubMed ID: 16419389
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid disposition in oral fluid after controlled smoked cannabis.
Lee D; Schwope DM; Milman G; Barnes AJ; Gorelick DA; Huestis MA
Clin Chem; 2012 Apr; 58(4):748-56. PubMed ID: 22273566
[TBL] [Abstract][Full Text] [Related]
12. Impact of oral fluid collection device on cannabinoid stability following smoked cannabis.
Anizan S; Bergamaschi MM; Barnes AJ; Milman G; Desrosiers N; Lee D; Gorelick DA; Huestis MA
Drug Test Anal; 2015 Feb; 7(2):114-20. PubMed ID: 24995604
[TBL] [Abstract][Full Text] [Related]
13. Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?
Lee D; Karschner EL; Milman G; Barnes AJ; Goodwin RS; Huestis MA
Drug Alcohol Depend; 2013 Jun; 130(1-3):68-76. PubMed ID: 23146820
[TBL] [Abstract][Full Text] [Related]
14. Appearance of hexahydrocannabinols as recreational drugs and implications for cannabis drug testing - focus on HHC, HHC-P, HHC-O and HHC-H.
Helander A; Johansson M; Villén T; Andersson A
Scand J Clin Lab Invest; 2024 Apr; 84(2):125-132. PubMed ID: 38619215
[TBL] [Abstract][Full Text] [Related]
15. Free and Glucuronide Urine Cannabinoids after Controlled Smoked, Vaporized and Oral Cannabis Administration in Frequent and Occasional Cannabis Users.
Huestis MA; Sempio C; Newmeyer MN; Andersson M; Barnes AJ; Abulseoud OA; Blount BC; Schroeder J; Smith ML
J Anal Toxicol; 2020 Oct; 44(7):651-660. PubMed ID: 32369162
[TBL] [Abstract][Full Text] [Related]
16. Oral fluid and plasma cannabinoid ratios after around-the-clock controlled oral Δ(9)-tetrahydrocannabinol administration.
Milman G; Schwope DM; Schwilke EW; Darwin WD; Kelly DL; Goodwin RS; Gorelick DA; Huestis MA
Clin Chem; 2011 Nov; 57(11):1597-606. PubMed ID: 21875944
[TBL] [Abstract][Full Text] [Related]
17. Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana.
Niedbala RS; Kardos KW; Fritch DF; Kardos S; Fries T; Waga J; Robb J; Cone EJ
J Anal Toxicol; 2001; 25(5):289-303. PubMed ID: 11499881
[TBL] [Abstract][Full Text] [Related]
18. Urinary Excretion Profile of Cannabinoid Analytes Following Acute Administration of Oral and Vaporized Cannabis in Infrequent Cannabis Users.
Sholler DJ; Zamarripa CA; Spindle TR; Martin EL; Kuntz D; Vandrey R; Grabenauer M
J Anal Toxicol; 2022 Oct; 46(8):882-890. PubMed ID: 35770374
[TBL] [Abstract][Full Text] [Related]
19. Detection of the marijuana metabolite 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid specimens and its contribution to positive results in screening assays.
Moore C; Ross W; Coulter C; Adams L; Rana S; Vincent M; Soares J
J Anal Toxicol; 2006 Sep; 30(7):413-8. PubMed ID: 16959132
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid concentrations in hair from documented cannabis users.
Huestis MA; Gustafson RA; Moolchan ET; Barnes A; Bourland JA; Sweeney SA; Hayes EF; Carpenter PM; Smith ML
Forensic Sci Int; 2007 Jul; 169(2-3):129-36. PubMed ID: 16963215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
